Nasopharyngeal carcinoma (NPC), a type of head and neck cancer, can be difficult to diagnose because its symptoms can be similar to that of other illnesses. With the Take 2: Prophecy Test, you can help your patients know if they have an NPC so they have better odds of managing and surviving the disease.
Take2 Test for NPC is the only early cancer screening test for NPC that is validated by a large-scale clinical trial on asymptomatic individuals. It makes use of the latest DNA technologies to detect human and NPC-associated Epstein-Barr Virus (EBV) DNA in the bloodstream. When NPC is present, cancer cells shed viral and human DNA into the blood.
THERE ARE TWO TYPES OF THIS TEST:
- Take 2 Prophecy™ Test will determine whether or not the patient has NPC. This test can detect NPC in patients at an earlier stage, when there is a better chance of recovery.
- Take 2 Monitoring Test will monitor the number of Epstein-Barr virus (EBV) DNA linked with the condition, after the patient has been diagnosed.